Wasay Humayun, MD
Family Medicine · Chicago, ILNPI 1013154327
Payments from drug & device makers
Across 16 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$102
- Bayer$82
- Ardelyx, Inc.$64
- Amgen$25
- Novo Nordisk$23
- Akebia Therapeutics Inc$19
- plus $49 from 3 others
What the payments were for
- Food & beverage$34395%
- Education$205%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 3 | $102 |
| Bayer | 4 | $82 |
| Ardelyx, Inc. | 3 | $64 |
| Amgen | 1 | $25 |
| Novo Nordisk | 1 | $23 |
| Akebia Therapeutics Inc | 1 | $19 |
| Aurinia Pharma U.S., Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Cranial Technologies, Inc | 1 | $15 |
How this compares
$363 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| InvokanaCanagliflozin | 20 | $11,274 |
| JanuviaSitagliptin Phosphate | 14 | $8,517 |
| LokelmaSodium Zirconium Cyclosilicate | 14 | $7,732 |
| Midodrine Hcl | 36 | $4,570 |
| Bumetanide | 26 | $1,277 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $1,150 |
| Nifedipine ErNifedipine | 27 | $1,009 |
| Zafirlukast | 11 | $965 |
| Tamsulosin Hcl | 42 | $437 |
| Fludrocortisone Acetate | 11 | $402 |
| Atorvastatin Calcium | 78 | $316 |
| Allopurinol | 29 | $295 |
| Losartan Potassium | 44 | $283 |
| Ketoconazole | 12 | $262 |
| Potassium Chloride | 18 | $192 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chicago
- Bradley TorphyChicago$3M
- Frank PhillipsChicago$1.6M
- Ayoade AkereChicago$484K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
- Jacqueline OlivoChicago$165K
- Sameer PanjwaniChicago$136K
- Igor AltmanChicago$64K
- Juan RojasChicago$40K
- Mark SimonChicago$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.